Genentech
The Department of Immunology at Genentech is seeking a highly talented, driven and motivated Scientist 3 to investigate novel biological mechanisms and potential therapeutic targets to treat inflammatory diseases. The successful candidate will lead projects that advance our understanding of the cellular and molecular mechanisms of adaptive and innate immunity, with a main emphasis on harnessing immunoregulatory mechanisms for reestablishing immune and tissue homeostasis under inflammatory conditions.
Headquarters
South San Francisco, California, United States
Company Size
10001+ employees
Founded
1976
Genentech is a research-driven biotechnology company that develops medicines through breakthrough science to treat people with serious and life‑threatening diseases. It discovers, advances and manufactures biologic therapies — including monoclonal antibodies and targeted medicines — across oncology, immunology, neuroscience and other therapeutic areas, moving candidates through discovery and clinical trials. Founded in 1976 and now part of the Roche group, Genentech is known for its patient-centered focus and for translating deep science into transformative, widely used medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genentech.
Scientist 3, Lung Biology & Inflammation
1000 Genentech, Inc.
Post-Doctoral Associate, Humphries Lab, Division of Innate Immunity, UMass Chan Medical School
UMass Chan Medical School
Postdoctoral Scientist
Oracle
Postdoctoral Scientist
Oracle
Post Doctoral Fellow - Department of Microbiology & Immunology - Lab of Dr. Igyarto
Thomas Jefferson University
Post Doc - Open Rank
UMass Chan Medical School